Compare EXK & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXK | AORT |
|---|---|---|
| Founded | 1981 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | EXK | AORT |
|---|---|---|
| Price | $11.59 | $43.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $13.31 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 14.9M | 304.0K |
| Earning Date | 03-10-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $337,137,000.00 | ★ $422,646,000.00 |
| Revenue This Year | $111.57 | $15.97 |
| Revenue Next Year | $64.09 | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.22 | 9.81 |
| 52 Week Low | $2.95 | $21.97 |
| 52 Week High | $11.72 | $48.25 |
| Indicator | EXK | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 67.59 | 40.55 |
| Support Level | $9.37 | $41.82 |
| Resistance Level | $10.60 | $45.99 |
| Average True Range (ATR) | 0.77 | 1.38 |
| MACD | 0.14 | -0.28 |
| Stochastic Oscillator | 96.16 | 33.07 |
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.